ResearcherDublin City UniversityActive in the last 2 years

Sara Noorani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5830-1397; OpenAlex author ID A5034101918. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

Fatty Acid Synthase (FASN) as a targeted therapeutic in acquired 5-fluorouracil resistance in pancreatic cancer. Co-author DOI 10.1016/j.biopha.2026.119273 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Naomi Walsh · 1 shared paper, 2026 · strength 0.30
- Paper Fatty Acid Synthase (FASN) as a targeted therapeutic in acquired 5-fluorouracil resistance in pancreatic cancer. DOI 10.1016/j.biopha.2026.119273 ↗
Jojanneke Stoof · 1 shared paper, 2026 · strength 0.30
- Paper Fatty Acid Synthase (FASN) as a targeted therapeutic in acquired 5-fluorouracil resistance in pancreatic cancer. DOI 10.1016/j.biopha.2026.119273 ↗
Paula Meleady · 1 shared paper, 2026 · strength 0.30
- Paper Fatty Acid Synthase (FASN) as a targeted therapeutic in acquired 5-fluorouracil resistance in pancreatic cancer. DOI 10.1016/j.biopha.2026.119273 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.